Skip to main content

Table 2 List of variants found in study strains and their clinical significance

From: Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype–phenotype correlation

Gene

Related drug

Nucleotide change

Suspected amino acid changes

No. of strains having variant among sensitive strains (%)

No. of strains having variant among resistant strains (%)

P value*

Previous report

Interpretation

gyrA

FQ

G61C

E21Q

30/30 (100)

6/6 (100)

> 0.05

Yes [22]

Susceptible

gyrA

FQ

C269T

A90V

0/30 (0)

2/6 (33.3)

0.024

Yes [23]

Resistance

gyrA

FQ

G280A

D94N

0/30 (0)

1/6 (16.7)

0.17

Yes [23]

Possible resistance

gyrA

FQ

A281G

D94G

0/30 (0)

1/6 (16.7)

0.17

Yes [23]

Possible resistance

gyrA

FQ

G284C

S95T

29/30 (96.7)

6/6 (100)

> 0.05

Yes [16]

Susceptible

gyrA

FQ

C846G

N282K

3/30 (10)

1/6 (16.7)

0.17

No

Susceptible

gyrA

FQ

G2003A

G668D

29/30 (96. 7)

6/6 (100)

> 0.05

Yes [22]

Susceptible

rpsL

SM

A128G

K43R

0/26 (0)

3/10 (30)

0.017

Yes [24]

Resistance

rpsL

SM

A262C

K88Q

0/26 (0)

1/10 (10)

0.298

Yes [24]

Possible resistance

embB

EMB

A916G

M306V

1/29 (3.4)

3/7 (42.9)

0.018

Yes [16]

Resistance

embB

EMB

G918A

M306I

0/29 (0)

2/7 (28.6)

0.033

Yes [16]

Resistance

embB

EMB

A916C

M306L

0/29 (0)

1/7 (14.3)

0.194

Yes [16]

Possible resistance

embB

EMB

A956C

Y319S

0/29 (0)

1/7 (14.3)

0.22

Yes [16]

Possible resistance

embB

EMB

A1061D

D354A

1/29 (3.4)

0/7 (0)

> 0.05

Yes [25]

Susceptible

embB

EMB

A1255G

I419V

0/29 (0)

1/7 (14.3)

0.194

No

Possible resistance

inhA

INH

T62C

I21T

0/21 (0)

1/15 (6.7)

> 0.05

Yes [16]

Possible resistance

inhA

INH

T74C

I25T

0/21 (0)

1/15 (6.7)

> 0.05

Yes [26]

Possible resistance

inhA

INH

T280G

S94A

0/21 (0)

2/15 (13.3)

0.167

Yes [16]

Possible resistance

katG

INH

923_924delinsAG

T308L

1/21 (4.8)

0/15 (0)

> 0.05

No

Susceptible

katG

INH

C944G

S315T

0/21 (0)

5/15 (33.3)

< 0.05

Yes [16]

Resistance

katG

INH

C944T

S315N

0/21 (0)

1/15 (6.7)

> 0.05

Yes [16]

Possible resistance

katG

INH

A1133C

L378R

0/21 (0)

1/15 (6.7)

> 0.05

No

Possible resistance

katG

INH

C1317A

Q439H

1/21 (4.8)

0/15 (0)

> 0.05

No

Susceptible

katG

INH

C1388A

R463L

16/21 (76.2)

12/15 (80)

> 0.05

Yes [16]

Susceptible

katG

INH

G1595A

A532V

1/21 (4.8)

0/15 (0)

> 0.05

No

Susceptible

katG

INH

G1715A

T572M

1/21 (4.8)

0/15 (0)

> 0.05

No

Susceptible

katG

INH

A1789C

Y597D

0/21 (0)

1/15 (6.7))

> 0.05

No

Possible resistance

katG

INH

T1873C

T625A

1/21 (4.8)

2/15 (13.3)

> 0.05

No

Susceptible

pncA

PZA

C53A

S18Ter

0/28 (0)

1/8 (12.5)

> 0.05

No

Possible resistance

pncA

PZA

A139C

T47P

0/28 (0)

1/8 (12.5)

> 0.05

Yes [16]

Possible resistance

pncA

PZA

241insT

H82Pfs

0/28 (0)

1/8 (12.5)

> 0.05

No

Possible resistance

pncA

PZA

T254G

L85R

0/28 (0)

1/8 (12.5)

> 0.05

Yes [16]

Possible resistance

rpoB

RFP

C38T

P13L

1/25 (4)

0/11 (0)

> 0.05

No

Susceptible

rpoB

RFP

C1333T

H445Y

0/25 (0)

1/11 (9.1)

> 0.05

Yes [27]

Possible resistance

rpoB

RFP

C1349T

S450L

0/25 (0)

10/11 (90.9)

< 0.001

Yes [27]

Resistance

rpoB

RFP

T1355C

L452P

1/25 (4)

0/11 (0)

> 0.05

Yes [27]

Susceptible

rpoB

RFP

G1655T

R552L

0/25 (0)

1/11 (9.1)

> 0.05

No

Possible resistance

rpoB

RFP

G1882T

A628S

1/25 (4)

0/11 (0)

> 0.05

No

Susceptible

rpoB

RFP

A3305C

K1102T

1/25 (4)

0/11 (0)

> 0.05

No

Susceptible

  1. FQ fluoroquinolones, SM streptomycin, EMB ethambutol, INH isoniazid, PZA pyrazinamide, RFP rifampin
  2. * P value resulting from Fisher’s exact test